Pancreatic Cancer

The Food and Drug Administration (FDA) has granted Fast Track Designation to the investigational adenovirus CAN-2409 plus prodrug Valtrex for the treatment of patients with pancreatic ductal adenocarcinoma.

Now having conquered three cancers and am fighting metastatic pancreatic cancer, scars from all the surgeries within the last 26 years have shown victories and hope.

From actor Patrick Dempsey saying that his late mother would be proud of his work at The Dempsey Center to a “General Hospital” actor discussing his cancer treatments, here’s what’s happening in the oncology space this week.

From Suzanne Somers’ death from metastatic breast cancer and Julia Louis-Dreyfus discusses her outlook on life post-diagnosis, here is what’s happening in the oncology space this week.

As Georgetown women’s basketball couch Tasha Butts died from cancer and “The Walking Dead” actor Erik Jensen revealed cancer diagnosis, here is what’s happening in the oncology space this week.

Results from the phase 3 NAPOLI trial show survival benefits for patients with metastatic pancreatic ductal adenocarcinoma treated with Onivyde plus oxaliplatin, leucovorin and fluorouracil.

Researchers have found alternatives to opioid pills, which reduces the risk of misuse and addiction in patients undergoing pancreatic cancer surgery.

As majority leader Steve Scalise announces his new cancer diagnosis and author Ibram X. Kendi reveals that he is cancer free, this is what’s happening in the oncology space this week.

Most of us dread, simply dread, hearing the words, “I’m sorry you have cancer.” I did.

Staging a laparoscopy can help patients with pancreatic cancer identify the stage of cancer, where it spread and what the best treatment may be, a recent study shows.

I remember my first trip to the “chemo room”.

From country music star, Toby Keith, providing an update on his cancer to the Duchess of York announcing her diagnosis, here’s what’s happening in the oncology space this week.

From actress and journalist Maria Menounos opening up about her pancreatic diagnosis to the Pennsylvania governor signing a bill for free screenings, here’s what’s happening in the oncology space this week.

From talk show host Jerry Springer’s death to “The Young and the Restless” star announcing a cancer diagnosis, here is what’s happening in the oncology space this week.

The COVALENT-102 trial will investigate BMF-219 in patients with non-small cell lung cancer, colorectal and pancreatic cancers.

Surviving cancer was tougher than my hardest days in the military. Here are some things I learned along the way.

The targeted therapy appeared to be safe and effective in treating patients with KRAS G12C mutated pancreatic cancer, according to results from a recent study.

The combination of pelareorep, Tecentriq, gemcitabine and Abraxane was granted FDA fast-track designation after demonstrating a 69% objective response rate in patients with advanced/metastatic pancreatic ductal adenocarcinoma.

Cancer made me realize that there is more to life than just work.

From “Star Trek” actors supporting the Pancreatic Cancer Action Network to Michelle Obama meeting with a sarcoma survivor and an update on Jane Fonda’s cancer, here’s what’s happening in the cancer space this week.

As a pancreatic cancer survivor, I realized how important it is to help others who are in the throes of their cancer experience.

From the death of “Schitt’s Creek” Emmy winning-producer “Ben Feigin” to “Good Charlotte” signer Joel Madden donating nearly $200,000 to an osteosarcoma nonprofit, here’s what’s happening in the cancer space this week.

The novel drug PY159 will be studied as a single agent and in combination with Keytruda for patients with certain solid tumors — including ovarian, pancreatic, lung, head and neck, colorectal and breast cancers.

Receiving a pancreatic cancer diagnosis has caused me to reexamine my spirituality, which led me to believe that my life is a line, rather than a single dot in time.

Treatment with FOLFIRINOX, a combination of several chemotherapy agents, prior to the surgical resection of pancreatic cancer increased survival outcomes when compared to historical data.